Menu

Blog

Archive for the ‘biotech/medical’ category: Page 799

Dec 11, 2022

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

Posted by in category: biotech/medical

Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.

The study findings were published in JAMA Oncology and led by Marco Del Chiaro, MD, division chief of surgical oncology in the University of Colorado Department of Surgery and visiting researcher Toshitaka Sugawara, MD, Ph.D.

“It’s critical to have large scale data that doctors can use to make decisions about plans for patients who qualify for surgery,” said author Marco Del Chiaro, MD, division chief of surgical oncology at the CU Cancer Center on the University of Colorado Anschutz Medical Campus.

Dec 11, 2022

Yale breakthrough may uncover the root cause of Alzheimer’s

Posted by in categories: biotech/medical, neuroscience

The fight against Alzheimer’s disease has been a tough one, but we are making progress. Not only have scientists created tech that can detect Alzheimer’s in a single brain scan, but some research has also shown that repurposable drugs could help find a cure.

Dec 11, 2022

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

Posted by in category: biotech/medical

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

The therapy, known as a bispecific antibody, binds to both T cells and multiple and directs the T cells— that can be enlisted to fight off diseases—to kill multiple cells. The researchers described this strategy as “bringing your army right to the enemy.”

The success of the off-the-shelf immunotherapy, called talquetamab, was even seen in patients whose was resistant to all approved multiple myeloma therapies. It uses a different target than other approved therapies: a receptor expressed on the surface of cancer cells known as GPRC5D.

Dec 11, 2022

A 1.3-micrometer-thin elastic conductor for wearable and implantable devices

Posted by in categories: biotech/medical, wearables

In recent years, engineers have been working to develop increasingly sophisticated and smaller electronic components that could power the devices of the future. This includes thin and stretchable components that could be easily worn on the skin or implanted inside the human body.

Researchers at RIKEN, Nanyang Technological University, National University of Singapore, University of Tokyo, and other institutes in Japan, Singapore and China have recently realized a new, elastic electrical conductor that is 1.3-micrometers thin. This conductor, introduced in a paper published in Nature Electronics, could advance the development of both wearable and implantable sensors.

“Ultrathin electronic devices can form a conformal interface with curved surfaces, are not perceivable by human when wearing, and do not induce strong foreign body rejection (FBR) when implanted in animals,” Zhi Jiang, one of the researchers who carried out the study, told TechXplore.

Dec 11, 2022

Gene expression data point to exercise as the most effective treatment for Alzheimer’s disease

Posted by in categories: biotech/medical, health, neuroscience

An analysis of 22 large-scale gene expression datasets pointed to exercise and activity in general as the most effective theoretical treatment for reversing gene expressions typical of Alzheimer’s disease. Fluoxetine, a well-known antidepressant, also showed effect, particularly when combined with exercise. Curcumin showed positive effects as well. The study was published in Scientific Reports.

Alzheimer’s disease is a complex neurodegenerative disorder that affects multiple brain regions. It is the most common disease that causes dementia and is very difficult to treat. In the course of the disease, abnormal collections of proteins called tau accumulate inside neurons.

Another type of protein clumps together to form so-called amyloid plaques that collect between neurons and disrupt cell functions. These and other changes harm the functioning of the brain across different regions and lead to dysfunction and death of brain cells.

Dec 11, 2022

Artificial womb concept revealed

Posted by in categories: biotech/medical, futurism

A German-based biotechnologist and filmmaker has presented his concept for an artificial womb. This futuristic device could allow a foetus to grow and develop outside the body, without the need for women to undergo pregnancy.

Dec 11, 2022

How the SIM card in your phone could make medicines cheaper

Posted by in categories: biotech/medical, mobile phones

Research from Imperial College London suggests that gold compouds recovered from discarded SIM cards can significantly lower the cost of making medicines.

Dec 11, 2022

Base editing: Revolutionary therapy clears girl’s incurable cancer

Posted by in category: biotech/medical

New way of altering DNA is used to engineer an “exciting”, experimental therapy for a 13-year-old girl.

Dec 11, 2022

Parrots Keep Attacking Poppy Farms To Get High On Opium

Posted by in categories: biotech/medical, food

They’re so much like humans. Hopefully this doesn’t hurt them in the long term.


Farms in India have reached out to the authorities after repeatedly being attacked by opium-addicted parrots.

Farmers in Madhya Pradesh say their opium crops are being ruined by parrots who keep returning to raid their farms in an attempt to get high. The farmers have been guarding the fields day and night to protect their poppies, but the birds are willing to risk it all to get their beaks on the opium, which is being farmed for medical purposes.

Continue reading “Parrots Keep Attacking Poppy Farms To Get High On Opium” »

Dec 11, 2022

Researchers Turn Cancer Cells Into Less Harmful Cell Types

Posted by in category: biotech/medical

Cancer cells are incredibly adaptable, much like stem cells. Researchers from the University of Basel have discovered substances that artificially mature breast cancer cells of the very aggressive triple-negative subtype and transform them into a state that is similar to normal cells.

Cancer occurs when cells grow uncontrollably and spread to other organs. Cancer cells are quite different from normal ones. Cancer cells are known for their remarkable adaptability to varied settings in the body as well as drug treatments. They resemble stem cells or cells at an early stage of development in this regard.

The prospect of artificially maturing (or, more accurately, differentiating) breast cancer cells as a strategy to transform them into a more normal kind of cell has been explored by researchers at the University of Basel and the University Hospital Basel.

Page 799 of 2,734First796797798799800801802803Last